Abstract:OBJECTIVE:To evaluate the efficacy and safety of Teicoplanin (TEC) in the treatment of Chinese patients with moderate and severe Gram positive (G(+)) coccus infections.METHODS:A prospective, multicenter, non-comparator control, open-label drug clinical trial of phase IV was conducted.RESULTS:Totally 156 cases with established and highly suspected G(+) coccus infections are enrolled. Mean age was 53.6 +/- 20.9 (9-93). The infections included: lower respiratory tract infections (66.0%), sepsis (9.0%), catheters-associated infections (5.1%), endocarditis (1.9%), leucopenia with fever (14.1%), bone-joint infections (1.3%), skin-soft tissue infections (7.7%), and other infections (10.9%). Eighty seven point eight percent of the patients suffered from severe underlying diseases, 28.2% (44/156) had immunocompromised conditions. 69.2% had received antibiotics previously (57.4% with cephalosporins and 28.7% with carbapenem, respectively). One hundred and thirty strains of G(+) cocci were isolated from 123 patients (78.8%). Among them methicillin-resistant Staphylococcus aureus (MRSA) accounted for 90.7% (49/54) and methicillin-resistant coagulase-negative Staphylococcus (MRCNS) 88.2% (30/34). The TEC susceptibility test for 105 strains showed that all of the Staphylococci and Enterococci were susceptible. In 121 strains tested for vancomycin, all of the Staphylococci but only 78.3% (18/23) of the Enterococci were susceptible. There were 18 strains of Gram negative bacilli and 1 strain of Candida A. isolated concomitantly with G(+) cocci from 17 cases. The total clinical effectiveness was 82.1% by ITT (156 cases) analysis and 85.2% by PP (135 cases) analysis, respectively. Bacteriologic eradication rate was 87.7%. Thirty three patients with negative culture result were empirically treated with TEC and had 96.8% of clinical effectiveness. The efficacy of TEC to different infections was similar. The total adverse effects, such as decrease in blood cells and transient abnormal liver functions, accounted only for 1.28%.CONCLUSIONS:Teicoplanin was a very effective antibiotic for G(+) coccus infections and safe for patients. In highly suspected infections with methicillin-resistant Staphylococci or Enterococci, TEC may be a choice for initial empirical treatment.

Glycopeptides Antibiotics Teicoplanin in Elder Patients with Lung Infection Due to MRSA:Evaluation of Efficacy and Safety

Teicoplanin and Vancomycin Treatment in Patients with Lung Infection of MRSA:A Clinical Evaluation

Efficacy of teicoplanin in treatment of Gram-positive coccal lower respiratory tract infection among elderly patients.

Teicoplanin in Treatment of Patients with Gram-positive Coccus Pulmonary Infections:A Clinical Study

Multicenter Randomized Controlled Clinical Trial on Teicoplanin Versus Vancomycin

Clinical comparison of several common anti-MRSA antibiotics in elderly patients with lung infection

Efficacy of vancomycin in treatment of pneumonia caused by methicillin-resistant Staphylococcus aureus in the elderly patients

Efficacy and Safety of Teicoplanin on Treatment of Pulmonary Tuberculosis Combined with Gram-Positive Cocci Infection in Lungs

Clinical research on efficacy of linezolid and vancomycin in treatment of senile patients with ventilator-associated pneumonia induced by MRSA

Efficacy and Safety of Teicoplanin on Treatment of Gram-positive Cocci in Lower Respiratory Tract Infection

[Clinical Study of Teicoplanin in the Treatment of Patients with Gram-Positive Cocci: the Chinese Experience].

Teicoplanin as an Effective Alternative to Vancomycin for Treatment of MRSA Infection in Chinese Population: A Meta-analysis of Randomized Controlled Trials

Effect of Herbal Tanreqing-injection Combined with Vancomycin in Treatment of MRSA Pneumonia and Antibiotic Resistance of the Pathogens

Efficacy of Teicoplanin in Treatment of Methicillin Resistant Staphylococcus Aureus Infections in Burn Wound Infection

Age-Related Differences in Vancomycin-Associated Nephrotoxicity and Efficacy in Methicillin-Resistant Staphylococcus aureus Infection: A Comparative Study between Elderly and Adult Patients

Effects of linezolid in the treatment of 32 senile patients with ventilator-associated pneumonia caused by methicillin resistant staphylococcus aureus

Treatment of Teicoplanin for Severe Brain Injury Complicated with Nosocomial Pneumonia.

Teicoplanin and Vancomycin in Treatment of MRSA Infection in Severe Burns Patients:A Clinical Observation

Necessity for higher teicoplanin doses in older adults: a multicenter prospective observational study in China

Drug resistant spectrum of staphylococcus aureus causing pulmonary infection

Retrospective analysis of hospital-acquired pneumonia caused by Staphylococcus aureus in elderly patients